Measurement of insulin resistance in VIVO

Drugs

Volumn 58, Issue SUPPL. 1, 1999, Pages 3-6

  Prato, Stefano Del ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Dipartimento di Medicina Clinica e Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAVENOUS GLUCOSE TOLERANCE TEST;

DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; PHENOTYPE;

EID: 0032700663     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958001-00002     Document Type: Article

References (16)

1. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997; 46: 63-9
2. DeFronzo RA, Ferrannini E. Insulin resistance: a mullifaceted syndrome for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94
3. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-73
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607
5. Del Prato S, Maran A, Bonora E, et al. The metabolic syndrome in the European population: the experience of the European Group on Insulin Resislance (EGIR). Diabates 1999; 48 Suppl. 1:A167
6. Del Prato S, Ferrannini E, DeFronzo RA. Evaluation of insulin sensitivity in man. In: Clarke WL, Lamer J, Pohl SL, editors. Methods in diabetes research. Vol. II. New York: J Wiley & Sons, 1986: 35-76
7. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86
8. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895-906
9. Ferrannini E, Vichi S, Beck-Nielsen H, et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996; 45: 947-53
10. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 1166-73
11. Ferrannini E, Natali A, Capaldo B, et al. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997; 30: 1144-9
12. Clausen JO, Borch-Johnsen K, Ibsen H, et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians.
13. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 1996; 98: 1195-209
14. Thorburn AW, Baldwin ME, Rosella G, et al. Features of syndrome X develop in transgenic rats expressing a non-insulin responsive phosplioenolpyruvate carboxykinase gene. Diabetologia 1999; 42: 419-26
15. Ortmeyer UK, Bodkin NL. Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulinresistant monkeys. Am J Physiol 1998; 274: G1005-10
16. Rossetti L, Stenbit AE, Chen W, et al. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest 1997; 100: 1831-9